Neural Substrates Underlying Impulsivity

Annals of the New York Academy of Sciences

Volumn 1008, Issue , 2003, Pages 160-169

  King, Jean A ^a   Tenney, Jeffrey ^a   Rossi, Victoria ^a   Colamussi, Lauralea ^a   Burdick, Stacy ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

ADHD; Animal models; Brain regions; Impulsivity; MRI

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; BEMESETRON; CHLORAMPHETAMINE; CITALOPRAM; METERGOLINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RITANSERIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONFERENCE PAPER; CORPUS STRIATUM; DECISION MAKING; HUMAN; IMPULSIVENESS; MONOAMINERGIC SYSTEM; NERVE CELL NETWORK; NEUROCHEMISTRY; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; REINFORCEMENT; REWARD; SEROTONIN RELEASE;

ANIMALIA;

EID: 1342284163     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1301.017     Document Type: Conference Paper

References (47)

1. KENT, L., F. MIDDLE, Z. HAWI, et al. 2001. Nicotinic acetylcholine receptor α 4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr. Genet. 11: 37-40.
2. WENDER, P. 1995. Attention Deficit Hyperactivity Disorder in Adults. Oxford University Press. New York.
3. EVENDEN, J.L. & C.N. RYAN. 1996. The pharmacology of impulsive behavior in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology 128: 161-170.
4. EVENDEN, J.L. & B. MEYERSON. 1999. The behavior of Spontaneously Hypertensive and Wistar Kyoto rats under a paced fixed consecutive number schedule. Psychopharmacology 63: 71-82.
5. NAKAMURA, K., M. KURASAWA & M. SHIRANE. 2000. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats. Brain Res. 862: 266-269.
6. EVENDEN, J.L. 1998. The pharmacology of impulsive behavior in rats III: the effects of amphetamine, haloperidol, imipramine, chlordiazapoxide and ethanol on a paced fixed consecutive number schedule. Psychopharmachology 138: 295-304.
7. EVENDEN, J.L. 1998. The pharmacology of impulsive behavior in rats IV: the effects of selective serotonergic agents on a paced fixed consecutive number schedule. Psychopharmachology 140: 319-330.
8. CARDINAL, R.N., D.R. PENNICOTT, C.L. SUGATHAPALA, et al. 2001. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292: 2499-2501.
9. BIEDERMAN, J. & S.V. FARAONE. 2002. Current concepts on the neurobiology of attention-deficit/hyperactivity disorder. J. Atten. Disord. 6(Suppl. 1): S7-S16.
10. GIEDD, J.N., F.X. CASTELLANOS, B.J. CASEY, et al. 1994. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am. J. Psychiatry 151: 665-669.
11. SCHWEITZER, J.B., D.O. LEE, R.B. HANFORD, et al. 2003. A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology 28: 967-973.
12. TEICHER, M.H., C.M. ANDERSON, A. POLCARI, et al. 2000. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat. Med. 6: 470-473.
13. HALE, T.S., A.R. HARIRI & J.T. MCCRACKEN. 2000. Attention-deficit/ hyperactivity disorder: perspectives from neuroimaging. Ment. Retard. Dev. Disabil. Res. Rev. 6: 214-219.
14. DURSTON, S. 2003. A review of the biological bases of ADHD: what have we learned from imaging studies? Ment. Retard Dev. Disabil. Res. Rev. 9: 184-195.
15. LEYTON, M., H. OKAZAWA, M. DIKSIC, et al. 2001. Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am. J. Psychiatry 158: 775-782.
16. DOLAN, M., W.J. DEAKIN, N. ROBERTS & I. ANDERSON. 2002. Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment? Psychol. Med. 32: 105-117.
17. HANNON, J. & D. HOYER. 2002. Serotonin receptors and systems: endless diversity? Acta Biol. Szeged. 46: 1-12.
18. LINNOILA, M., M. VIRKKUNEN, M. SCHEININ, et al. 1983. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 33: 2609-2614.
19. COCCARO, E.F., L.J. SIEVER, H.M. KLAR, et al. 1989. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch. Gen. Psychiatry 46: 587-599.
20. EVANS, J., H. PLATTS, S. LIGHTMAN & D. NUTT. 2000. Impulsiveness and the prolactin response to d-fenfluramine. Psychopharmacology 149: 147-152.
21. SOUBRIÈ, P. 1986. Serotonergic neurons and behavior. J. Pharmacol. 17: 107-112.
22. WOGAR, M.A., C.M. BRADSHAW & E. SZABADI. 1993. Effects of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers. Psychopharmacology 111: 239-243.
23. RICHARDS, J.B. & L.S. SEIDEN. 1995. Serotonin depletion increases impulsive behavior in rats. Soc. Neurosci. Abstr. 21: 1693.
24. DALLEY, J.W., E.A. THEOBALD, D.M. EAGLE, et al. 2002. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26: 716-728.
25. OGAWA, S., TM. LEE, A.S. NAYAK & P. GLYNN. 1990. Oxygenation- sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med. 14: 68-78.
26. OGAWA, S., R.S. MENON, D.W. TANK, et al. 1993. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. Biophys. J. 64: 803-812.
27. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28: 897-916.
28. 15O PET rCBF. J. Cereb. Blood Flow Metab. 16: 755-764.
29. LOGOTHETIS, N.K., J. PAULS, M. AUGATH, et al. 2001. Neurophysiological investigation of the basis of the fMRI signal. Nature 412: 150-157.
30. STEIN, E.A., R. RISINGER & A.S. BLOOM. 2000 Functional MRI in pharmacology. In Functional MRI. C.T.W. Moonen and P.A. Bandettini, Eds.: 525-538. Springer-Verlag. New York.
31. ARCHER, T. 1989. Neurotoxin-induced cognitive and motor activity modifications: a catecholamine connection. In Attention Deficit Disorder: Clinical and Basic Research. T. Sagvolden and T. Archer, Jr., Eds.: 287-322. Hillsdale Erlbaum. New York.
32. SHAYWITZ, M.B.A., J.H. KLOPPER, R.D. YAGER & J.W. GORDON. 1976. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature 261: 153-155.
33. SAGVOLDEN, T., M.A. METZGER, H.K. SHIORBECK, et al. 1992. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav. Neural Biol. 58: 13-112.
34. MOOK, D.M. & A. NEURINGER. 1994. Different effects of amphetamine on reinforced variations versus repetitions in spontaneously hypertensive rats (SHR). Physiol. Behav. 56: 939-944.
35. SAGVOLDEN, T., H. AASE, P. ZEINER & D.F. BERGER. 1998. Altered reinforcement mechanisms in attention-deficit hyperactivity disorder. Behav. Brain Res. 94: 61-71.
36. BOIX, F., S.W. QIAO, F. KOLPUS & T. SAGVOLDEN. 1998. L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit hyperactivity disorder. Behav. Brain Res. 94: 153-162.
37. GIROS, B., M. JABER, S.R. JONES, et al. 1996. Hyperlocomotion and indifference to cocaine amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
38. RUSSELL, V.A. 2002. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav. Brain Res. 130: 191-196.
39. STRUPP, J.P. 1996. Stimulate: a GUI based fMRI analysis software package. Neuroimage 3: S607.
40. BARBELIVIEN, A., S. RUOTSALAINEN & J. SIRVIO. 2001. Metabolic alterations in the pre-frontal and cingulate cortices are related to behavioral deficits in a rodent model of attention deficit hyperactivity disorder. Cereb. Cortex 11: 1056-1063.
41. JENTSCH, J.D. & J.R. TAYLOR. 1999. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146: 373-390.
42. BERQUIN, P.C., J.N. GIEDD, L.K. JACOBSEN, et al. 1998. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 50: 1087-1093.
43. ANDERSON C.M., A. POLCARI, S.B. LOWEN, et al. 2002. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am. J. Psychiatry 159: 1322-1328.
44. RUSSELL, V.A. 2003. In vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats. Metab. Brain Dis. 18: 161-168.
45. RUSSELL, V., A. DE VILLIERS, T. SAGVOLDEN, et al. 1995. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. 676: 343-351.
46. FILIPEK, P.A., M. SEMRUD-CLIKEMAN, R.J. STEINGARD, et al. 1997. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48: 589-601.
47. TRINH, J.V., D.L. NEHRENBERG, J.P. JACOBSEN, et al. 2003. Differential psychostimulannt-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 118: 297-310.